SPP1 and prostate carcinoma: identified SPP1hi tumor-associated macrophages as mediators of immunotherapy resistance through adenosine-dependent immunosuppression during prostate cancer progression, proposing SPP1 transcript levels as a potential stratification biomarker (129).